S&P 500   3,115.70 (-0.14%)
DOW   27,855.50 (-0.28%)
QQQ   202.98 (-0.19%)
CGC   17.59 (+14.82%)
BABA   182.92 (-1.26%)
GE   11.42 (-0.78%)
T   36.65 (-3.55%)
F   8.81 (-1.01%)
BAC   32.80 (-0.43%)
DIS   147.53 (-0.57%)
S&P 500   3,115.70 (-0.14%)
DOW   27,855.50 (-0.28%)
QQQ   202.98 (-0.19%)
CGC   17.59 (+14.82%)
BABA   182.92 (-1.26%)
GE   11.42 (-0.78%)
T   36.65 (-3.55%)
F   8.81 (-1.01%)
BAC   32.80 (-0.43%)
DIS   147.53 (-0.57%)
S&P 500   3,115.70 (-0.14%)
DOW   27,855.50 (-0.28%)
QQQ   202.98 (-0.19%)
CGC   17.59 (+14.82%)
BABA   182.92 (-1.26%)
GE   11.42 (-0.78%)
T   36.65 (-3.55%)
F   8.81 (-1.01%)
BAC   32.80 (-0.43%)
DIS   147.53 (-0.57%)
S&P 500   3,115.70 (-0.14%)
DOW   27,855.50 (-0.28%)
QQQ   202.98 (-0.19%)
CGC   17.59 (+14.82%)
BABA   182.92 (-1.26%)
GE   11.42 (-0.78%)
T   36.65 (-3.55%)
F   8.81 (-1.01%)
BAC   32.80 (-0.43%)
DIS   147.53 (-0.57%)
Log in

Amphastar Pharmaceuticals News Headlines (NASDAQ:AMPH)

$18.31
+0.06 (+0.33 %)
(As of 11/20/2019 11:56 AM ET)
Today's Range
$18.08
Now: $18.31
$18.45
50-Day Range
$17.11
MA: $19.32
$20.70
52-Week Range
$16.71
Now: $18.31
$25.43
Volume4,772 shs
Average Volume217,889 shs
Market Capitalization$859.47 million
P/E Ratio87.19
Dividend YieldN/A
Beta1.17

Headlines

Amphastar Pharmaceuticals (NASDAQ AMPH) News Headlines

Source:
DateHeadline
$80.28 Million in Sales Expected for Amphastar Pharmaceuticals Inc (NASDAQ:AMPH) This Quarter$80.28 Million in Sales Expected for Amphastar Pharmaceuticals Inc (NASDAQ:AMPH) This Quarter
www.americanbankingnews.com - November 19 at 3:54 AM
Zacks: Brokerages Expect Amphastar Pharmaceuticals Inc (NASDAQ:AMPH) Will Post Earnings of $0.05 Per ShareZacks: Brokerages Expect Amphastar Pharmaceuticals Inc (NASDAQ:AMPH) Will Post Earnings of $0.05 Per Share
www.americanbankingnews.com - November 17 at 2:17 PM
Amphastar Pharmaceuticals to Present at the Jefferies London Healthcare ConferenceAmphastar Pharmaceuticals to Present at the Jefferies London Healthcare Conference
finance.yahoo.com - November 15 at 7:46 AM
Amphastar Pharmaceuticals, Inc. (AMPH) Management on Q3 2019 Results - Earnings Call TranscriptAmphastar Pharmaceuticals, Inc. (AMPH) Management on Q3 2019 Results - Earnings Call Transcript
seekingalpha.com - November 10 at 10:44 PM
Amphastar Pharmaceuticals (NASDAQ:AMPH) Issues Quarterly  Earnings Results, Beats Expectations By $0.02 EPSAmphastar Pharmaceuticals (NASDAQ:AMPH) Issues Quarterly Earnings Results, Beats Expectations By $0.02 EPS
www.americanbankingnews.com - November 9 at 5:31 PM
Edited Transcript of AMPH earnings conference call or presentation 7-Nov-19 10:00pm GMTEdited Transcript of AMPH earnings conference call or presentation 7-Nov-19 10:00pm GMT
finance.yahoo.com - November 8 at 6:10 PM
Amphastar Pharmaceuticals Inc (AMPH) Q3 2019 Earnings Call TranscriptAmphastar Pharmaceuticals Inc (AMPH) Q3 2019 Earnings Call Transcript
www.fool.com - November 8 at 1:10 PM
BRIEF-Amphastar Pharma Posts Q3 Adj Earnings Per Share Of $0.10BRIEF-Amphastar Pharma Posts Q3 Adj Earnings Per Share Of $0.10
www.msn.com - November 7 at 11:49 PM
Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended September 30, 2019Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended September 30, 2019
finance.yahoo.com - November 7 at 6:48 PM
Amphastar Pharmaceuticals (AMPH) Set to Announce Earnings on ThursdayAmphastar Pharmaceuticals (AMPH) Set to Announce Earnings on Thursday
www.americanbankingnews.com - November 2 at 9:51 AM
Amphastar Pharmaceuticals Inc (NASDAQ:AMPH) Given Average Rating of "Hold" by BrokeragesAmphastar Pharmaceuticals Inc (NASDAQ:AMPH) Given Average Rating of "Hold" by Brokerages
www.americanbankingnews.com - November 1 at 11:03 PM
Amphastar Pharmaceuticals to Release Third Quarter Earnings and Hold Conference Call on November 7th, 2019Amphastar Pharmaceuticals to Release Third Quarter Earnings and Hold Conference Call on November 7th, 2019
finance.yahoo.com - November 1 at 8:45 AM
Is  Amphastar Pharmaceuticals Inc (AMPH) A Good Stock To Buy?Is Amphastar Pharmaceuticals Inc (AMPH) A Good Stock To Buy?
finance.yahoo.com - October 28 at 6:17 PM
 Brokerages Anticipate Amphastar Pharmaceuticals Inc (NASDAQ:AMPH) Will Announce Quarterly Sales of $78.23 Million Brokerages Anticipate Amphastar Pharmaceuticals Inc (NASDAQ:AMPH) Will Announce Quarterly Sales of $78.23 Million
www.americanbankingnews.com - October 27 at 5:54 AM
How Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) Can Impact Your Portfolio VolatilityHow Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) Can Impact Your Portfolio Volatility
finance.yahoo.com - October 21 at 9:00 AM
How Much Did Amphastar Pharmaceuticals, Inc.'s (NASDAQ:AMPH) CEO Pocket Last Year?How Much Did Amphastar Pharmaceuticals, Inc.'s (NASDAQ:AMPH) CEO Pocket Last Year?
finance.yahoo.com - September 21 at 11:48 AM
A Comprehensive Study Exploring Substance Abuse Treatment Market | Key Players Alkermes, Allergan, GSK, Pfizer, Accord HealthcareA Comprehensive Study Exploring Substance Abuse Treatment Market | Key Players Alkermes, Allergan, GSK, Pfizer, Accord Healthcare
www.marketwatch.com - September 10 at 2:26 PM
Amphastar (AMPH) Presents At 2019 Wells Fargo Healthcare Conference - SlideshowAmphastar (AMPH) Presents At 2019 Wells Fargo Healthcare Conference - Slideshow
seekingalpha.com - September 6 at 10:06 AM
Global Naloxone Market Industry Analysis, Product Capacity, Growth Demand and Future Forecast Period Till 2025Global Naloxone Market Industry Analysis, Product Capacity, Growth Demand and Future Forecast Period Till 2025
www.marketwatch.com - August 30 at 9:30 AM
Amphastar Pharmaceuticals to Present at the Wells Fargo 2019 Healthcare ConferenceAmphastar Pharmaceuticals to Present at the Wells Fargo 2019 Healthcare Conference
finance.yahoo.com - August 29 at 10:45 AM
Does Amphastar Pharmaceuticals (NASDAQ:AMPH) Have A Healthy Balance Sheet?Does Amphastar Pharmaceuticals (NASDAQ:AMPH) Have A Healthy Balance Sheet?
finance.yahoo.com - August 22 at 10:17 AM
Epinephrine Market 2019 | Statistical Analysis, Market Size, Share, and Forecast till 2028Epinephrine Market 2019 | Statistical Analysis, Market Size, Share, and Forecast till 2028
www.marketwatch.com - August 16 at 6:09 PM
Vitamin K Market value to hit $1 billion by 2025: Global Market Insights, Inc.Vitamin K Market value to hit $1 billion by 2025: Global Market Insights, Inc.
www.globenewswire.com - August 14 at 9:11 AM
Amphastar Pharmaceuticals, Inc. (AMPH) Q2 2019 Results - Earnings Call TranscriptAmphastar Pharmaceuticals, Inc. (AMPH) Q2 2019 Results - Earnings Call Transcript
seekingalpha.com - August 11 at 10:26 PM
Edited Transcript of AMPH earnings conference call or presentation 7-Aug-19 9:00pm GMTEdited Transcript of AMPH earnings conference call or presentation 7-Aug-19 9:00pm GMT
finance.yahoo.com - August 8 at 10:51 AM
Amphastar Pharmaceuticals Inc (AMPH) Q2 2019 Earnings Call TranscriptAmphastar Pharmaceuticals Inc (AMPH) Q2 2019 Earnings Call Transcript
www.fool.com - August 7 at 11:52 PM
BRIEF-Amphastar Pharmaceuticals Q2 GAAP Earnings Per Share $0.96BRIEF-Amphastar Pharmaceuticals Q2 GAAP Earnings Per Share $0.96
www.msn.com - August 7 at 10:15 PM
Amphastar Pharmaceuticals (AMPH) Q2 Earnings and Revenues Beat EstimatesAmphastar Pharmaceuticals (AMPH) Q2 Earnings and Revenues Beat Estimates
finance.yahoo.com - August 7 at 10:15 PM
Amphastar Pharmaceuticals EPS beats by $0.03, beats on revenueAmphastar Pharmaceuticals EPS beats by $0.03, beats on revenue
seekingalpha.com - August 7 at 5:13 PM
Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended June 30, 2019Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended June 30, 2019
finance.yahoo.com - August 7 at 5:13 PM
Amphastar Pharmaceuticals to Release Second Quarter Earnings and Hold Conference Call on August 7,Amphastar Pharmaceuticals to Release Second Quarter Earnings and Hold Conference Call on August 7,
www.nasdaq.com - August 5 at 9:41 AM
Amphastar Pharmaceuticals to Release Second Quarter Earnings and Hold Conference Call on August 7, 2019Amphastar Pharmaceuticals to Release Second Quarter Earnings and Hold Conference Call on August 7, 2019
finance.yahoo.com - August 5 at 9:41 AM
Should You Be Holding Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH)?Should You Be Holding Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH)?
finance.yahoo.com - July 23 at 5:14 PM
Is Amphastar Pharmaceuticals Inc (AMPH) A Good Stock To Buy ?Is Amphastar Pharmaceuticals Inc (AMPH) A Good Stock To Buy ?
finance.yahoo.com - June 30 at 9:34 AM
Momenta, Amphastar settle generic Lovenox drug patent caseMomenta, Amphastar settle generic Lovenox drug patent case
www.reuters.com - June 26 at 5:15 PM
United States : Amphastar Pharmaceuticals to Present at the BMO Prescriptions for Success Healthcare ConferenceUnited States : Amphastar Pharmaceuticals to Present at the BMO Prescriptions for Success Healthcare Conference
www.marketwatch.com - June 26 at 5:15 PM
Amphastar Pharmaceuticals (AMPH) Presents At BMO 2019 Prescriptions For Success Healthcare Conference - SlideshowAmphastar Pharmaceuticals (AMPH) Presents At BMO 2019 Prescriptions For Success Healthcare Conference - Slideshow
seekingalpha.com - June 26 at 5:15 PM
Amphastar Pharmaceuticals to Present at the BMO Prescriptions for Success Healthcare ConferenceAmphastar Pharmaceuticals to Present at the BMO Prescriptions for Success Healthcare Conference
finance.yahoo.com - June 24 at 5:44 PM
Momenta Pharmaceuticals Announces Settlement Agreement with Amphastar Resolving Enoxaparin Sodium Injection LitigationMomenta Pharmaceuticals Announces Settlement Agreement with Amphastar Resolving Enoxaparin Sodium Injection Litigation
www.marketwatch.com - June 19 at 11:23 AM
Amphastar settles litigation with Momenta and SandozAmphastar settles litigation with Momenta and Sandoz
seekingalpha.com - June 19 at 11:23 AM
Amphastar Pharmaceuticals, Inc. Announces Settlement in Litigation with Momenta and SandozAmphastar Pharmaceuticals, Inc. Announces Settlement in Litigation with Momenta and Sandoz
finance.yahoo.com - June 19 at 11:23 AM
United States : Amphastar Pharmaceuticals to Present at the Raymond James Life Sciences and MedTech Healthcare ConferenceUnited States : Amphastar Pharmaceuticals to Present at the Raymond James Life Sciences and MedTech Healthcare Conference
www.marketwatch.com - June 17 at 5:59 PM
Introducing Amphastar Pharmaceuticals (NASDAQ:AMPH), A Stock That Climbed 33% In The Last Three YearsIntroducing Amphastar Pharmaceuticals (NASDAQ:AMPH), A Stock That Climbed 33% In The Last Three Years
finance.yahoo.com - June 14 at 4:59 PM
Amphastar Pharmaceuticals to Present at the Raymond James Life Sciences and MedTech Healthcare ConferenceAmphastar Pharmaceuticals to Present at the Raymond James Life Sciences and MedTech Healthcare Conference
finance.yahoo.com - June 14 at 11:40 AM
Amphastar Pharmaceuticals (AMPH) Presents At Jefferies 2019 Healthcare Conference - SlideshowAmphastar Pharmaceuticals (AMPH) Presents At Jefferies 2019 Healthcare Conference - Slideshow
seekingalpha.com - June 7 at 6:01 PM
New Product Approvals But No Cash Generation At AmphastarNew Product Approvals But No Cash Generation At Amphastar
seekingalpha.com - June 3 at 9:43 AM
Amphastar Pharmaceuticals, Inc. (AMPH) Q1 2019 Results - Earnings Call TranscriptAmphastar Pharmaceuticals, Inc. (AMPH) Q1 2019 Results - Earnings Call Transcript
seekingalpha.com - May 12 at 4:41 PM
Edited Transcript of AMPH earnings conference call or presentation 9-May-19 9:00pm GMTEdited Transcript of AMPH earnings conference call or presentation 9-May-19 9:00pm GMT
finance.yahoo.com - May 10 at 5:40 PM
Amphastar Pharmaceuticals (AMPH) Q1 Earnings and Revenues Surpass EstimatesAmphastar Pharmaceuticals (AMPH) Q1 Earnings and Revenues Surpass Estimates
www.nasdaq.com - May 10 at 9:49 AM
Amphastar Pharmaceuticals to Present at the Bank of America Merrill Lynch Healthcare Conference 2019Amphastar Pharmaceuticals to Present at the Bank of America Merrill Lynch Healthcare Conference 2019
finance.yahoo.com - May 10 at 9:49 AM
This page was last updated on 11/20/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel